3.1. Provide laboratory-testing services for chlamydia, gonorrhea and syphilis and for other diseases as identified by ADHS (See Exhibit One - Required Data Elements for Monthly and Annual Reports). 3.2. Provide syphilis serologic testing in the form of both a non-Treponemal test as well as a Treponemal test. 3.3. Provide stand alone, U.S. Food and Drug Administration (FDA) approved nucleic acid amplification test (NAAT) direct testing for the qualitative detection of chlamydia trachomatis and Neisseria gonorrhea as well as single specimen dual direct testing for the qualitative detection of chlamydia trachomatis and Neisseria gonorrhea. 3.4. Perform and provide laboratory tests and specimen collection kits for up to fifty (50) clinical sites. This includes providing and maintaining a stock of shipping materials by site, specimen transport, provision of test results to providers within a specified timeframe, and the collection and reporting of State-mandated positive results. 3.5 To perform laboratory tests to detect chlamydia trachomatis, Neisseria gonorrhea, and Treponema pallidum
